PRESS RELEASE published on 04/09/2025 at 14:10, 9 months 25 days ago Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments Immunic, Inc. announces pricing of $5.1 million registered direct offering led by Aberdeen Investments for clinical pipeline of therapies. Funds to be used for clinical trials and operations Registered Direct Offering Immunic Inc. Clinical Pipeline Thérapies Aberdeen Investments
BRIEF published on 04/01/2025 at 12:35, 10 months 3 days ago Immunic, Inc. Announces Participation in Key April Conferences Biotechnology Conférences Immunic Inc. Vidofludimus Calcium Neuroprotection
BRIEF published on 04/01/2025 at 12:35, 10 months 3 days ago Immunic, Inc. annonce sa participation aux principales conférences d'avril Biotechnologie Conférences Immunic Inc. Neuroprotection Vidofludimus Calcique
PRESS RELEASE published on 04/01/2025 at 12:30, 10 months 3 days ago Immunic, Inc. to Participate in Scientific and Industry Conferences in April Immunic, Inc. to participate in scientific and industry conferences in April, including American Academy of Neurology 2025 Annual Meeting and German Biotech Days 2025 Immunic Inc. Industry Conferences Scientific Conferences American Academy Of Neurology German Biotech Days
BRIEF published on 03/03/2025 at 12:35, 11 months 1 day ago Immunic to Join March Conferences to Present Research Biotechnology Investor Relations Conférences Antiviral Research Virology
BRIEF published on 03/03/2025 at 12:35, 11 months 1 day ago Immunic participera aux conférences de mars pour présenter ses recherches Biotechnologie Conférences Relations Avec Les Investisseurs Recherche Antivirale Virologie
PRESS RELEASE published on 03/03/2025 at 12:30, 11 months 1 day ago Immunic to Participate in Scientific and Investor Conferences in March Immunic to participate in scientific and investor conferences in March including the 34th Annual Meeting of the Society for Virology in Hamburg, Germany, and Leerink Partners Global Healthcare Conference in Miami Biotechnology Investor Conferences Clinical Pipeline Immunic Scientific Conferences
BRIEF published on 02/26/2025 at 12:35, 11 months 6 days ago Immunic partage des données prometteuses sur le vidofludimus calcique au Forum ACTRIMS 2025 Sclérose En Plaques Neuroprotection Vidofludimus Calcique Activation De Nurr1 Essai CALLIPER
BRIEF published on 02/26/2025 at 12:35, 11 months 6 days ago Immunic Shares Promising Data on Vidofludimus Calcium at ACTRIMS Forum 2025 Multiple Sclerosis Vidofludimus Calcium Neuroprotection Nurr1 Activation CALLIPER Trial
PRESS RELEASE published on 02/26/2025 at 12:30, 11 months 6 days ago Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis Immunic presents key data on vidofludimus calcium at ACTRIMS Forum 2025, highlighting its potential in multiple sclerosis. Phase 2 CALLIPER trial results expected in April Clinical Trial Multiple Sclerosis Immunic Vidofludimus Calcium ACTRIMS Forum 2025
Published on 02/04/2026 at 22:25, 1 hour 22 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 7 hours 32 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 8 hours 2 minutes ago Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 8 hours 47 minutes ago Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 20:54, 2 hours 53 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 3 hours 11 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 3 hours 46 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 4 hours 52 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 5 hours 6 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 5 hours 43 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 5 hours 43 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 6 hours 2 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 6 hours 2 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL